Mawer Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-122,387
Closed -$21.7M 99
2020
Q1
$21.7M Buy
122,387
+2,025
+2% +$381K 0.2% 69
2019
Q4
$23M Buy
120,362
+9,730
+9% +$1.76M 0.19% 71
2019
Q3
$18.6M Sell
110,632
-17,127
-13% -$2.79M 0.17% 71
2019
Q2
$21.4M Sell
127,759
-37,945
-23% -$5.25M 0.14% 88
2019
Q1
$24.3M Buy
165,704
+13,530
+9% +$1.96M 0.17% 80
2018
Q4
$20.3M Sell
152,174
-5,910
-4% -$969K 0.17% 83
2018
Q3
$30.1M Sell
158,084
-210
-0.1% -$38.6K 0.23% 75
2018
Q2
$26.4M Sell
158,294
-180,387
-53% -$29M 0.21% 76
2018
Q1
$57M Buy
338,681
+39,906
+13% +$6.69M 0.48% 58
2017
Q4
$48.9M Sell
298,775
-48,344
-14% -$8.68M 0.4% 59
2017
Q3
$71.1M Buy
347,119
+17,360
+5% +$4.04M 0.61% 54
2017
Q2
$80.2M Buy
329,759
+74,610
+29% +$17.5M 0.74% 47
2017
Q1
$61M Buy
255,149
+32,440
+15% +$7.55M 0.59% 57
2016
Q4
$46.8M Buy
+222,709
New +$46.1M 0.48% 61

Other funds holding AGN

Mawer Investment Management's AGN Position: Q2 2020 in Review

Mawer Investment Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 122,387 shares — an estimated $21.7M sold.

Mawer Investment Management first reported a position in AGN in Q4 2016 and held it in 14 quarters. The position peaked at $80.2M in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Mawer Investment Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Mawer Investment Management sold 122,387 Allergan plc shares in Q2 2020, an estimated $21.7M.
  • Mawer Investment Management first reported a position in Allergan plc in Q4 2016 and held it in 14 quarters.
  • Mawer Investment Management's Allergan plc position peaked at $80.2M in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Mawer Investment Management's 13F filing for Q2 2020, filed 10 Aug 2020.